Infection with highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b viruses has affected dairy cows in the United States, prompting investigation into bovine host defense factors. Research examined the myxovirus resistance proteins, bMx1 and bMx2, within differentiated bovine cells following HPAI H5N1 infection.
bMx1 and bMx2 Response to H5N1
Both proteins were more strongly induced in mammary cells compared to tracheal cells. Overexpression of bMx1 significantly inhibited seasonal influenza A viruses (IAVs), low-pathogenic, and highly pathogenic avian influenza viruses, including H5N1 2.3.4.4b, but not influenza B viruses. Conversely, knockdown of bMx1 resulted in enhanced IAV growth. bMx1 inhibited early stages of viral replication, reducing viral transcription and subsequent steps in the viral replication cycle.
Viral Resistance Mechanisms
Mutations known to reduce human MxA (hMxA) activity impaired bMx1 function, and mutations in the viral nucleoprotein (NP) associated with resistance to hMxA also reduced virus sensitivity to bMx1. Phylogenetic analysis indicated that a small minority (>0.03%) of avian H5N1 2.3.4.4b viruses already carried these NP mutations. This suggests that while current H5N1 viruses largely remain susceptible to bMx1, viral evolution or reassortment could drive Mx resistance and increase pandemic risk. The importance of this research highlights the innate antiviral immune responses of cows to influenza viruses, specifically focusing on Mx proteins as a key part of the defense system against different influenza viruses, including highly pathogenic strains. Further, the findings demonstrate similarities between the mechanisms of antiviral activity of bovine Mx1 and the human equivalent MxA protein.